ENROLLMENT COMPLETE FOR PRESTIGE LP CERVICAL DISC CLINICAL TRIAL

Medtronic, Inc. (NYSE:MDT) announced today the completion of enrollment in the PRESTIGE(R) LP Cervical Disc clinical trial, Medtronic's third major artificial cervical (neck) disc trial designed to explore new technologies for the treatment of degenerative spine disease. The information gathered from this clinical trial will help support an application to the FDA for future commercial sale of the device in the United States.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051207005162&newsLang=en)